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Extensive cross reactivity among the parainfluenza- 
mumps-NDV group of myxoviruses has been observed in man and 
experimental animals. These observations have led to great 
confusion concerning the relationships between these viruses, 
since variation is seen in different individuals and in 
different animal species. The observation of heterologous 
antibody production against members of this group other than 
the virus shown by isolation to be the infective agent has 
led to misgivings concerning the serologic diagnosis of 
infection with these agents. A still unanswered question 
is whether heterologous antibody represents de novo production 
of that antibody in an individual, or is an anamnestic response 
seen only in individuals with previous experience with the 
virus to which heterologous response is evoked. The question 
arises as to whether these viruses share common structural 
antigenic components, as is the case with the influenza viruses. 
In the present study experiments were conducted to 
characterize the primary, secondary and heterologous antibody 
responses with regard to 19S and JS antibody production in 
monkeys inoculated with mumps and/or DA virus. In addition, 
absorption of sera with viral antigens was carried out to 
determine if heterologous antibody v/ould react with the 
antigen which had caused its increased production. 
Elucidation of the nature of heterologous antibody 
response is important for understanding the basic relation- 

2 
ships of members of this group.. Furthermore, the understanding 
of these interrelationships is necessary for evaluation of 
serologic response in clinical diagnostic and epidemiologic 
studies. The possible role of the heterologous response as 
protective mechanism against viral infection is worthy of 
consideration. 

REVIEW OF LITERATURE 
General Consideration of Myxoviruses with Special Reference 
to the Parainfluenza-Mumps-NDV Group 
The name myxovirus was suggested in 195^ to classify 
those viruses which could be related to Influenza A virus on 
*3 
the basis of physical, chemical and biological properties, ~ 
The criteria for inclusion in this group are: l) ability to 
hemagglutinate fowl erythrocytes, 2) presence of viral receptor 
destroying enzyme, 3) removal of erythrocyte receptors by 
receptor-destroying enzyme of vibrio cholerae filtrate, 4) 
removal of "normal inhibitor" from serum by receptor-destroying 
enzyme, 5) growth in amnionic cavity of chick embryo, 6) size 
of 80-150 mu , 7) sensitive to ether, 8) stable when stored at 
o . 
-70 C, 9) ENA virus. In addition to the influenza viruses, 
mumps virus and Newcastle Disease virus (NDV), several other 
viruses which meet the criteria of myxoviruses have been 
isolated from man and animals; these are grouped together as 
the parainfluenza viruses. 
The parainfluenza viruses have been isolated from many 
geographic areas, from several host species, and have been 
found associated with a variety of clinical states. These 
viruses were originally named for place of isolation, various 
biological properties, host species or individual, or associated 
clinical syndrome. This lead to a diverse nomenclature for a 
group of related viruses, some strains of which seemed identical. 
Andrewes et al. suggested name parainfluenza and proposed 
those viruses which would make up the first three members of 

this group.'" Accordingly, parainfluenza-1 includes Sendai 
(hemagglutinating virus of Japan) and hemadsorption type-2 
(HA-2) viruses, parainfluenza-2 includes croup-associated (CA) 
virus, and parainfluenza-3 includes hemadsorption type-1 (HA-l) 
virus. Parainfluenza-4 was isolated in 1959 from adults and 
32 
children with respiratory illnesses. 
The name parainfluenza-5 has been proposed for a group of 
23 
viruses, commonly found in captive simian populations and recently 
2k 45 
in humans, including DA virus and SA virus. 9 y The original 
human isolation of DA virus was accomplished by Hsiung et al. 
?4 
from a patient with infectious hepatitis. It was demonstrated 
that this myxovirus was antigenically indistinguishable from 
SV-5 found in monkeys. 
Studies have shown many cross reactions between different 
parainfluenza viruses. These viruses have also been shown to 
cross react with mumps virus and NDV. As will be enumerated 
below the cross reactions occurring among these viruses are 
far from consistent, varying from species to species and from 
individual to individual. The close relationship of mumps 
and KDV to the parainfluenza viruses was recognized by Andrewes 
et al., but because of wide acceptance of the existing names 
for these viruses they were not considered as parainfluenza 
L 
viruses. Furthermore, clinically these two viruses are not 
associated with respiratory illnesses which are characteristic 
of symptomatic infection with the parainfluenza viruses. 
Numerous studies have failed to demonstrate any cross reactivity 
between any of the strains of influenza and the parainfluenza, 
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mumps or Newcastle Disease viruses. > ^4, jjO,40 therefore 
seems reasonable to consider parainfluenza-mumps-NDV to be a 
group of related myxoviruses, distinct from the influenza 
viruses. 
Distribution of Parainfluenza Antibodies in Human Populations 
Several serological surveys of populations from around the 
world have indicated that these viruses are ubiquitous and that 
the incidence of antibodies to each virus is similar in the 
different areas studied. LaPlaca and Mosovivi studied a large 
number of sera from India, Italy and Colorado. They found 
86-97.5$ positive reactors to parainfluenza-3, 60-80$ to 
parainfluenza-1 and 8-22$ to parainfluenza-2.'"1 In New Haven 
a study of 304 hospitalized patients showed the following 
incidences of positive serologic reactions: parainfluenza-1, 
54$; parainfluenza-2, 63$; parainfluenza-3, 83$; DA virus, 
74$; and mumps, 70$.c Chanock found 90$ of young adult males 
he tested to have antibody against parainfluenza-2.1 A study 
of residents of southern Louisiana showed prevalence of 
antibodies against these viruses to be: 75$ for parainfluenza-3, 
37$ for parainfluenza-2, 19$ for HA-2 and 9$ for Sendai virus."" 
Clinical States Associated with Parainfluenza-Mumps-NDV Infections 
in Man 
The parainfluenza viruses have been most commonly isolated 
from children and adults with respiratory illnesses. The most 
common symptoms are rhinnorhea, fever and cough, occassionally 
43 
symptoms of pneumonia are seen. The most serious condition 
definitely known to be caused by these agents is viral croup 
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8 10 21 52 
in infants and young children. ’ ’ These agents, 
particularly parainfluenza-1, are the most common cause of 
croup in children under 2 years old. The clinical syndrome 
of parotitis caused by mumps is well known. Newcastle Disease 
virus infection has rarely been documented in humans, and then 
only in association with mild conjunctivitis. ^5 The serological 
studies cited above would indicate all of these viruses, except 
NDV, are associated with high incidence of subclinical infection. 
In a study by Horstmann and Hsiung, parainfluenza-2 virus was 
21 52 
isolated from three cases of sudden unexplained death of infants. ’ 
This suggests that these viruses may be associated with serious 
sequelae in infants. 
Parainfluenza Virus Infections in Animal Populations 
The viruses of the parainfluenza-mumps-NDV group are also 
widespread among domestic animal populations. Parainfluenza-3 
is the etiologic agent for "shipping fever" in cattle, a 
1 20 57 
respiratory illness manifested only when cattle are crowded. ’ ’ J 1 
Seventy per cent of cattle slaughtered in the United States have 
2 
antibody to parainfluenza-3. Parainfluenza-3 has recently been 
isolated from fatal cases of pneumonia occurring in patas monkeys 
12 
crowded after transportation from Africa to England. The 
monkeys were shown to acquire parainfluenza-3 after captivity, 
and the virus isolated was similar to that found in humans. 
Hsiung has reported 791<> of monkeys arriving in New Haven to 
23 
have parainfluenza-3 antibodies. DA virus is very common in 
captive monkeys, but antibody against this virus which is 
2k 
identical to the simian virus, SV-5> is rare in wild monkeys. 
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This evidence suggests that parainfluenza-3 and -5 may be 
acquired by susceptible animals after they are brought into 
contact with human environment. Incidence of antibody 
against these viruses in laboratory animals received in New 
Haven was determined by Hsiung et al. Monkeys, rabbits and 
guinea pigs had high incidence of antibody against all members 
of this group except NDV, hamsters had only DA antibodies, while 
23 
mice and chickens had none. It is important to keep these 
data in mind when evaluation experiments utilizing laboratory 
animals. 
Cross Beactivity Among the Parainfluenza-Mumps-NDV Group 
Cross Beactivity in Man: In 1956. Chanock isolated CA virus 
(parainfluenza-2) from infants with croup. At this time he 
noted that four of eight patients with mumps showed a 
heterologous rise in HI anitbody to this newly isolated 
myxovirus.1 Subsequently, Chanock et al. studied two separate 
acute episodes of febrile illness in nursery schools, in one 
parainfluenza-1 was shown to be the etiologic agent and in the 
other parainfluenza-3. Heterologous antibody rise was seen in 
both populations to the non-infecting one of these two viruses 
with 33$ involved in the parainfluenza-1 outbreak having 
parainfluenza-3 rise, whereas 12$ of the other group showed 
heterologous rise. Most of those with heterologous response had 
had pre-existing antibodies. The viruses which were isolated 
produced no heterologous response in hamsters without pre-existing 
antibody.The greater incidence of heterologous parainfluenza-3 
antibody was believed due to greater previous experience with this 

3 
virus. An earlier study by Chanock of children with respiratory 
illnesses found no heterologous rise to parainfluenza-1 or -2 
or mumps and only 1 in 10 with parainfluenza-1 had a rise to 
8 
parainfluenza-3. 
The patient in whom the original isolation of parainfluenza-4 
was made showed heterologous response to parainfluenza-3, but 
not parainfluenza-1 or -2. It has been shown that adults, but 
not children, have heterologous response to mumps when infected 
Op 
with parainfluenza-4. ~ 
Cross reactivity with parainfluenza-5 in humans is poorly 
understood. Chanock concluded the low number of individuals 
with CF antibody to SV-5 had this as a result of infection with 
Q 
parainfluenza-2. He concluded, that there is no evidence 
for human infection caused by this agent. Evidence is cited 
above that DA virus indistinguishable from SV-5 can cause human 
25 
infection. 
The antigenic relationship between mumps and NDV has been 
observed since 1949. In this case previous experience with 
NDV is presumed to be unnecessary for the commonly observed NDV 
antibody found in patients convalescent from mumps, and it is 
believed naturally occurring NDV antibody in the population is 
83 
the result of mumps infections. " The close relationship of 
these two viruses is borne out by common biological properties 
of hemolysin activity^ and their proximity on the erythrocyte 
42 
receptor gradient. 
DeMeio and Walker found 22 of 24 young adult patients 
with clinical mumps to have heterologous antibody rise to 
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parainfluenza-1. They also found positive correlation between 
antibodies to parainfluenza-1 and mumps in sera from well 
medical students. From these findings they concluded, "It 
is quite likely that much, and perhaps most, of the antibody 
against HVJ (parainfluenza-l) found in the general population 
of the United States is attributable to mumps virus infection 
rather than actual experience with HVJ.” J In the years since 
this study, parainfluenza-1 has been shown to be a common 
11 21 
respiratory pathogen in the United States. 3 Heterologous 
responses to parainfluenza-2 and -3 have also been noted in 
mumps patients.1 Lennette et al. studied sera from 47 mumps 
patients and found 40$ heterologous rise to parainfluenza-1, 
21$ to parainfluenza-3, and 8$ to parainfluenza-2. They found 
40 
the incidence of heterologous response to increase with age. 
These workers along with others previously cited propose that 
in order for a heterologous antibody response to occur among 
the parainfluenza and mumps viruses, pre-existing antibodies 
9 16 
must be present. It is of note that in the instances cited,'1 
demonstration of cross reactivity lead to the false conclusion 
that parainfluenza-1 and -5 were not a frequent cause of human 
infection in certain populations with antibodies against these 
agents. 
Hsiung et al. studied antibody response in 10 patients 
in whom parainfluenza viruses were isolated. Extensive cross 
reactions were seen in these patients. Most puzzling among 
these patients was a 1 month old infant who had no titer to 
parainfluenza-1, -2, -3, mumps or DA when parainfluenza-2 was 
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isolated; however, 3 months later had antibody to all of these 
25 
viruses demonstrated. 
Cross Reactivity in Experimental Animals: Animal experiments 
have in general showed extensive cross reactivity among these 
viruses similar to that seen in human studies with some 
differences according to the species used. Chanock et_ ai. 
showed that guinea pigs which have parainfluenza-3 antibodies 
will have an increase in this antibody when inoculated with 
mumps or parainfluenza-1, whereas all animals without pre¬ 
existing parainfluenza-3 antibodies and some with them failed 
8 
to show this heterologous response. Cook et al. found 
individual guinea pigs to show different heterologous responses 
which indicated relationships between: parainfluenza-1 and -2; 
14 
parainfluenza-1 and -3; parainfluenza-3 and mumps. Using 
chicken and guinea pig immune sera prepared against parainfluenza-1, 
mumps and NDV, Ishida et al. showed cross reactivity between 
27 
these viruses. 1 Similar relationships between these viruses 
have been shown using rabbit immune sera.'5"' Hamsters inoculated 
with parainfluenza-3 showed no anitbody rise to parainfluenza-1 
or -2, or mumps. J ') 
Heterologous antibody responses to inoculation with mumps 
and DA virus in different species of laboratory animals was 
carried out by Hsiung. Only animals without antibodies to 
mumps and DA were used. Babbits developed mumps antibody 
after DA inoculation, but only showed specific response to mumps 
inoculation. Guinea pigs showed heterologous response to both 
viruses, whereas hamsters showed only specific antibody rise. 
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Chickens had heterologous rise to parainfluenza-3 and HDV 
(they had previous inoculation with NDV) after mumps or DA. 
Monkeys inoculated with DA virus showed heterologous response 
to mumps and parainfluenza-3, and rarely to parainfluenza-1 or 
-2. Hsiung considered the possibility that the animals had 
previous contact with the viruses to which they showed a 
heterologous rise since these responses were seen in those 
23 
species which had high incidence of natural infection. 
Studies of Antibody Structure 
Antigen-Antibody Absorption: Absorption of antibodies by viral 
particles is one method of demonstrating the presence of 
structural antigenic components shared by more than one virus. 
A known specific viral antigen is added to serum, antigen- 
antibody complexes are allowed to form, and the virus particles 
(with any attached antibody) are removed from the mixture. Serum 
is tested for antibody against those viruses in which common 
components are suspected before and after the absorption 
procedure. A decrease in titer of antibody against a virus 
other than that used for the absorption is evidence of common 
antigen shared by these two viruses. Removal of viral particles 
from the serum mixture is accomplished by ultracentrifugation 
or absorption onto erythrocytes, the latter being limited to 
those viruses which exhibit hemagglutination. 
Using antibody absorption techniques, Jensen and Francis 
have determined that k2 strains of Influenza A share 18 antigenic 
2Q 




In the only published report of absorption analysis of the 
parainfluenza-mumps-M)V group, Hsiung found only homologous 
antibody was removed by DA virus and parainfluenza-3 antigen. 
In this study sera was used from a chimpanzee which had been 
inoculated with DA virus had shown an antibody rise to DA, 
23 
parainfluenza-1 and -3, and mumps. Jensen et al. have shown that 
certain strains of influenza virus will not absorb antibody to 
parainfluenza-1.^ 
Determination of 19S and 7S Components: In recent years it has been 
noted that two types of antibody, differing in molecular size, are 
formed in response to antigenic stimulus. A macroglobulin with 
sedimentation coefficient of 19 Sverberg units (19S) appears in 
the initial phase of a primary response. Later smaller globulin, 
5 
7S, appears and persists for long periods of time. This smaller 
antibody seems to be the important measurable factor in the 
"immunological memory system." A secondary response is characterized 
by rapid production of large amounts of 7S antibody, formerly 
thought without production of 19S. Svehag and Mandel have shown 
that in rabbits inoculated with polio-virus about 50 times as much 
antigen is required to cause JS production as 19S production, and 
that if doses of antigen insufficient to induce 7S production are 
A8 
used a secondary response on reinoculation will not occur. Further 
they have shown that the secondary response, in their test system, 
is characterized by a production of 19S antibody similar to that 
49 
seen in the primary response. The JS antibody 
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responded to secondary stimulus with a rapid 200-fold increase 
so that 19S, present in much smaller quantities, could only be 
detected when separated from 7S by ultracentrifugation. Svehag 
and Mandel also cite evidence that cessation of 19S, 4-5 days 
after inoculation appears due to loss of antigenic stimulus 
which is necessary for continued 19S production, but not JS 
49 
production once it is initiated. They postulate two different 
cell populations produce these different types of antibody. The 
conclusions of Svehag and Mandel are in aggreement with those 
of Uhr and Finkelstein who studied the immunologic response 
50 
of rabbits inoculated with bacteriophage. 
Separation of 19S and 7S is accomplished by differential 
centrifugation across a density gradient of sucrose or cesium 
chloride.'' It has been found that 2-mecaptoethaftol (2-ME) 
will destroy activity of 19S but not 7S antibody.' This has 
been shown to occur by breaking disulfide bonds in the 
17 
macroglobulins. Treatment of serum with 2-ME is a useful 
way of determining presence of 19S antibody; however, it will 
show decrease of antibody titer only if 19S makes up a large 
part of the antibody present. The relative insensitivity of 
this technique accounts for the conclusion reached by some that 
41,51 
there is no production of 19S in a secondary antibody response 

MATERIALS AND METHODS 
Virus Strains 
Mumps. Two strains of mumps virus were used. One strain 
(DD^) was obtained from Dr. Werner Henle who had isolated it from 
a patient in 195^* Isolation was in Hela cell tissue culture, 
and it was passed four times before storage at -70°C. Before 
use in these experiments the virus was passed six times by 
amniotic inoculation of 6 day old chick embryos, the fluid 
7 
being harvested after 7 days. The fluid contained 10 EID per 
ml. The second strain used was Enders strain mumps virus. 
DA Virus. Tissue culture fluid from monkey kidney tissue 
cultures infected with DA virus (Eh-32rj)* was used. The fluid 
6 5 
contained 10 *' TCID per ml. 
Parainfluenza-3. Parainfluenza-3 (Ph-10)*was grown in 
monkey kidney tissue culture in the presence of SV-5 antisera. 
The fluid contained 10^*^ TCID per ml. 
Animal Inoculations 
Monkeys ft1-k. Four rhesus monkeys were inoculated with 
mumps virus, numbers 1 and 3 via the parotid duct as described 
O 1 
by Johnson and Goodpasture^ and numbers 2 and ^ by instillation 
of the inoculum into the nasopharynx. One ml. of inoculum 
containing 10' EID of DD^ strain mumps virus was given to each 
animal. 
After inoculation the animals were watched daily for signs 
of illness. There were no changes in temperature, parotid size 
or consistancy, or in eating pattern to indicate illness. 
* Number of passages in rhesus tissue culture 
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Attempts to isolate mumps virus from saliva and urine were 
carried out. Saliva was collected 2, h, 6, 8, 11 and 14 days 
after inoculation and urine on days 6 and l4. The saliva was 
collected with a sterile cotton swab which was pulverized in 
1.5 ml. of Hanks balanced salt solution containing 150 mg. 
streptomycin and 150 units penicillin. One-tenth ml. of urine 
was put into 1.5 ml. of the same Hanks solution. These samples 
were cleared by centrifugation. Of each sample in Hank’s 
solution 0.1 ml. was inoculated into each of three 6 day old 
chick embryos and 0.2 ml. into each of three 3 day old chick 
embryo fibroblast cultures. The egg fluids were harvested 
after 5 days and checked for hemagglutination of 0.5$ chick 
erythrocytes. The fluids from each group of three eggs were 
pooled and inoculated into 3 more chick embryos and hemagglutination 
looked for after 5 more days. The chick embryo fibroblast 
cultures were checked for hemadsorption of guinea pig erythrocytes 
43 
at 3, 5, 7 and 10 days. All attempts at isolation of mumps 
virus were negative. 
Blood for serologic study was obtained from each animal 
previous to inoculation and 4, 6, 8, 11, 14, 19, 22, 30, 57 and 
90 days after inoculation. Serum was separated from clot and 
stored at -20°C until used for antibody determination. 
Ninety days after the first inoculation with mumps virus, 
inoculation of these animals with DA or parainfluenza-3 virus 
was carried out. Monkeys #1 and 2 were given inoculation with 
DA virus. One ml. of monkey kidney tissue culture fluid 
6 5 
containing 10 TCID per ml. was given intravenously and 1 ml. 
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intranasally to each monkey. Monkeys #3 and k received similar 
amounts of tissue culture fluid containing 10^*5 TCID of 
parainfluenza-3 virus. Blood was collected from each animal 
at 5> 8, l4, 21 and 30 days after inoculation. 
Monkeys #2 and 3 were given a second inoculation with mumps 
virus 6 months after the first and 3 months after the inoculation 
with DA in case of #2 and parainfluenza-3 in case of #3 (Table l). 
The virus.usedi was the same as that used for the first inoculation 
o 
having been stored at -70 C. One ml. was given to each monkey 
intravenously and 1 ml. intranasally. Blood was collected 
before and 2, 4, 8, 11, 15, 22 and 30 days after inoculation. 
Inoculation of Monkeys #5-7« Three monkeys which had 
previously been inoculated with different viruses were selected 
for mumps inoculation to study the response of animals with 
known histories of infection. Monkey #5 had been inoculated 
with parainfluenza-1 five months previously; monkey #6 with 
polio-1 five months previously; and monkey #7 had received 
DA virus ten months and parainfluenza-1 eight months previously 
(Table l). Inoculation with mumps was carried out by intra¬ 
venous and intramuscular injection of 10' EID of Enders strain 
mumps virus per animal (Table l). Serum was collected before 
and 2, U, 7> l4, 21 and 30 days after inoculation. No signs 
of illness occurred in these animals. Isolation of virus was 
not attempted. 
Chimpanzee Inoculation with DA Virus. Stored sera from 
chimpanzee (Mack #50) in which DA virus had been inoculated 
was furnished by Dr. Hsiung to provide sera representing a 

17 
primary response to DA virus inoculation. This animal which 
had no pre-existing DA antibodies had been inoculated with DA 
virus intravenously. 
Antibody Determinations 
Hemagglutination-inhibition (Hi) titers were determined 
using the viral antigens of the parainfluenza-mumps-NDV group. 
The complement fixation test was not used because it has been 
found unsuitable for evaluation of activity against DA virus 
due to anticomplementary effect when commercial preparations 
25 
of complement is used with DA antigen. * Studies in humans 
have shown HI and neutralization tests to be more specific than 
11 
CF for these viruses. Hemagglutination-inhibition tests were 
chosen as it was desired to test large numbers of sera against 
several antigens which could be done with one test system; whereas, 
both tissue cultures and embryonated eggs would be required to 
do neutralization tests against all the viruses concerned. 
Hemagglutination-Inhibition Test. 
1. Serum Treatment. Sera were heat inactivated at 
56°C for 30 minutes. Serum agglutinins were removed by adding 
packed washed guinea pig erythrocytes to serum diluted 1:5, 
keeping the mixture in ice bath for 30 minutes, and then re¬ 
moving the erythrocytes by centrifugation. An equal volume 
of 2% kaolin in PBS was added to the 1:5 dilution of serum 
to remove nonspecific serum inhibitors. After 20 minutes at 
room temperature the kaolin was removed by centrifugation 
22 
yielding a 1:10 dilution of serum. 
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2. Antigen Preparation. Mumps viral antigen 
obtained from Lederle (lot number: 2540-36); Parainfluenza-3 
and DA were grown in rhesus monkey kidney tissue cultures and 
the fluids used for hemagglutinating antigens. Parainfluenza-3 
was grown in presence of SV-5 antisera. 
3. Preparation of 0Guinea Pig Erythrocyte Suspension. 
Guinea pig erythrocytes were washed three times by suspension 
in PBS and centrifugation. After the third washing the packed 
cells were suspended in approximately an equal volume of PBS. 
The exact percentage of erythrocytes in this suspension was 
determined by use of capillary hematocrit tubes which were 
centrifuged in an International microcapillary centrifuge. The 
cell suspension was appropriately diluted to produce a 0.5cl> 
suspension in PBS. 
4. Test Procedure. Two-fold dilutions of the treated 
serum in 0.2 ml. amounts were made with PBS in plastic cup 
panels by use of a serologic diluter. Two-tenths ml. of 
antigen containing 4 hemagglutinating units was added to each 
cup. After one hour at room temperature, 0.4 ml. of the 
erythrocyte suspension was added. The panels were examined 
for hemagglutination after two hours. The HI titer was recorded 
as the reciprocal of the highest serum dilution showing no 
hemagglutination. 
Analysis of Antibody Components 
Treatment of Sera with Mecaptoethanol, Serum was heat 
inactivated, serum agglutinins removed with guinea pig 
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erythrocytes and. diluted. 1:5 with PBS. To 0.9 ml. of this 
treated serum 0.1 ml. of 1 molar mecaptoethanol (2-ME) in PBS 
was added; 0.1 ml. PBS was added to control sera. The serum 
was incubated overnight at 4°C to allow inactivation of 19S 
antibody. After incubation the serum was treated with kaolin 
and HI tests performed. 
Centrifugation of Sera Across Sucrose Gradient. Sucrose 
gradients were prepared in 5 ml. cellulose nitrate ultracentrifuge 
tubes. The first method used was to layer 0.9 ml. amounts of 
sucrose solutions ranging from 37$ on the bottom to 12.5$ on top. 
kk 
This produced a layered symmetric gradient. The second type of 
gradient used was an asymmetric sucrose gradient prepared by drop- 
wise addition of 40$ sucrose to a 10$ solution. The asymmetric 
kl 
gradients were prepared with the apparatus and method of Speir. 
Two-tenths ml. of serum, which had been treated with guinea pig 
erythrocytes to remove serum agglutinins, was layered over the 
gradient. The gradients were centrifuged for 16.5 hours at 
35>000 RPM in a Spinco Model L ultracentrifuge with a SW39 
centrifuge head. After centrifugation, fractions of the gradient 
were collected in drops from a needle hole in bottom of the 
tube. Nine fractions of 0.5 ml. were collected from each tube. 
Each fraction was diluted 1:2 with PBS. To 0.5 ml. of each 
diluted fraction 0.05 ml. of 1 molar 2-ME was added; 0.05 ml. of 
PBS was added to the remaining 0.5 ml. The fractions were kept 
. o 
overnight at 4 C before doing antibody determinations. 
Absorption of Antibody with Viral Antigens 
Antigen Preparations. 1. Mumps--viral antigen obtained 
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from Lederle (Lot number: 2540-36) which had hemagglutination 
titer of 1:1280 was used. 
2. DA virus—tissue culture fluid from monkey kidney cell 
tissues infected with DA virus was used for antigen source. To 
1000 ml. of the fluid 20 ml. of packed guinea pig erythrocytes 
was added. Adsorption of virus onto the erythrocytes took place 
in 4- hours at room temperature. The mixture was centrifuged at 
1500 PPM for 15 minutes and the supernatant fluid removed. To 
the guinea pig erythrocytes which had virus attached, 50 ml. of 
o 
PBS was added. This mixture was kept in 37 C water bath for 1 hour 
with intermittent shaking. After the elution of virus the erythrocytes 
were removed by centrifugation and the supernatant used for antigen. 
The final antigen solution had hemagglutination titer of 1:1280. 
3. Parainfluenza-3--antigen was prepared from infected 
monkey kidney tissue culture by erythrocyte adsorption-elution 
as described for DA virus. The antigen preparation had 
hemagglutination titer of 1;640. 
A. Newcastle Disease virus--infected egg fluid with 
hemagglutination titer of 1:640 was used (California strain 1191*0* 
Absorption of Sera. Equal volumes of 1:10 dilution of serum 
treated as described above in preparation for HI tests and the 
1 0 
antigen suspension were mixed and kept overnight at 4 C. The 
virus-antibody aggreagates were removed by ultracentrifugation at 
40,000 BPM for 4 hours in Spinco Model L ultracentrifuge with No. 40 
centrifuge head. The supernatant fluid was checked for 
hemagglutination and treated with guinea pig cells when 
necessary to remove agglutinins. To control sera PBS was added 




Antibody Response to First Mumps Inoculation 
Monkeys #1-4. (Figures 1-4) Inoculation of mumps virus 
into monkeys #1-4 caused production of mumps HI antibody which 
reached maximal levels 19 to 22 days after inoculation in all 
four animals. The antibody levels were first detectible 
between 4 and 8 days in low titer. This low level of initial 
antibody production is characteristic of primary response to 
a viral infection. Since these animals were inoculated via 
parotid duct or nasopharynx it was assumed that this antibody 
response indicated an infection occurred in spite of failure 
to isolate mumps virus. The titers of mumps HI antibody 
decreased after 22 to 30 days, but were still significant at 
90 days after inoculation. 
Only monkey #1 showed a heterologous antibody response to 
DA virus after mumps inoculation. As shown on Figure 1, this 
response closely paralleled that of the response to mumps. All 
four animals had initial DA virus HI titers of 40 to 80, yet 
only one showed a heterologous response. None of the animals 
responded with a rise of parainfluenza-3 HI antibody. High 
levels of antibody against parainfluenza-3 were present at the 
time of mumps inoculation. 
Monkeys #5-7. (Figures 5-7) These monkeys which were 
inoculated by intravenous and intramuscular injection of Enders 
strain of mumps virus responded with a rise of mumps antibody 
less pronounced than that seen in monkeys #1-4. Monkey #6 
had initial mumps HI titer of 40 while the other two had titers 
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of 10. The presence of pre-existing antibodies indicates the 
probability in one, and perhaps all three, of previous 
experience with mumps virus. 
None of the animals showed heterologous response with 
antibodies to DA virus or parainfluenza-3 to which they had 
significant pre-existing HI antibody titers. 
Antibody Response to DA Inoculation 
Monkeys #1 and 2. (Figures 1 & 2) Inoculation of DA 
virus was followed by a rise in DA virus HI antibodies in 
both animals. This rise was marked at 5 days and reached 
maximal level at 8 days. The rapidity and magnitude of this 
response are characteristic of a secondary, or anamnestic, 
antibody response. 
Both monkeys showed an eight-fold heterologous rise in 
HI antibody to mumps after DA Inoculation. This response was 
of less magnitude than that seen after the first mumps inoculation, 
but was of similar temporal progression. Monkey #1 showed a 
four-fold increase in HI antibody to parainfluenza-3 after 
DA virus. 
Antibody Response to Parainfluenza-3 Inoculation 
Monkeys #3 and 1+. (Figures 3 & 4) Monkey #3 which had HI 
titer of 1280 against parainfluenza-3 at the time of inoculation 
showed no significant response to this virus. Monkey jjh which 
had initial titer of 160 showed a rapid response characteristic 
of an anamnestic rise. 
A four-fold increase in DA titer was seen in monkey #3> 
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but no significant heterologous response in monkey #4. 
Neither animal showed a heterologous response against mumps. 
Antibody Response to Second Mumps Inoculation 
Monkeys #2 and 3» (Figures 2 & 3) Both monkeys showed an 
increase in mumps HI titer of more than 100-fold by eight days. 
At the time of this inoculation, both animals had low levels 
of mumps HI antibody which had persisted since first mumps 
inoculation six months previously. 
Neither animal showed an increase in DA virus HI antibody 
titers. The sera from these monkeys were also tested for 
antibodies against parainfluenza-2 and NDV; no antibodies to 
these viruses were found. 
Sensitivity of HI Antibodies to 2-ME Treatment 
The antibody titers of sera after treatment with 2-ME 
are shown on Figures 1-7. A two-fold or greater decrease in 
HI antibody titer against mumps is seen in all sera tested 
from monkeys #1-4 during the first fourteen days after 
inoculation (Figures 1-4). This is further evidence that 
these animals experienced a primary infection witn mumps. A 
two to four-fold decrease after 2-ME treatment is seen in 
sera obtained 2, 4 and 7 days after mumps inoculation,from 
monkeys #5 and 7> But not from #6 which had higher pre-existing 
antibodies and less response to inoculation. A decrease in mumps 
titer with 2-ME treatment is also seen in sera from monkeys #1 
and 2 taken during the period of heterologous antibody rise 
following DA inoculation (Figures 1 & 2). The titer of mumps 
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antibody following a second inoculation with mumps was not 
decreased by 2-ME treatment (Figure 2). ; }. 
As shown in Figures 1-7, DA virus and parainfluenza-3 
antibody titers were found not to be affected by 2-ME 
treatment in all these sera tested. None of these sera 
represented a primary inoculation, although both homologous 
and heterologous rises were seen in the groups tested. Sera 
from chimpanzee which had an HI titer of 20 three days 
after primary DA inoculation was treated with 2-ME; antibody 
activity could no longer be detected at 1 to 10 dilution (not 
shown in figures). 
Results of Separation of 19S and 7S Antibodies by Sucrose 
Gradient Centrifugation 
Because of the inability of 2-ME treatment to detect 19S 
antibody in the presence of greater amounts of 7S antibody, 
certain sera were centrifuged across sucrose gradients to 
separate 19S from 7S antibodies. The results of centrifugation 
are shown in Figures 8-l6. The hemagglutination-inhibiting 
activity of each fraction is indicated as the reciprocal of 
the highest dilution of the fraction giving complete inhibition 
in the system described for antibody determination. This HI 
activity represents the HI antibody present in each fraction, 
but does not represent the actual serum antibody titer because 
the dilution in each fraction depends upon the sedimentation 
properties of the antibodies. The recorded titers indicate 
the relative amount of HI antibody in each fraction. The 
findings shown in Figures 8-l6 indicate that the 2-ME labile 
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activity--19S antibody--is limited to the lower fractions, 
whereas 2-ME stable activity--7S antibody-- is concentrated in 
the higher fractions. 
Activity of serum from monkey §1 eight days after first 
mumps inoculation is shown in Figure 8. All mumps antibody 
was in the bottom fraction, whereas all DA activity is in 
fractions 5-7* The antibody against mumps was all destroyed 
by 2-ME, whereas that against DA virus was not. These findings 
confirm those presented above ( Figure l) that soon after mumps 
inoculation 19S antibody against mumps is present, but not against 
DA virus. In contrast, serum taken 90 days after mumps inoculation 
and just before DA inoculation had no 19S antibody (Figure 9). 
As shown in Figure 1, monkey #1 had a rise to mumps 
following DA inoculation. It is also shown on Figure 1, that 
there was a decrease in mumps antibody, but not DA antibody, 
after 2-ME treatment of serum obtained 8 days after DA 
inoculation. The results of centrifugation of this sera 
obtained during the period of homologous DA rise and 
heterologous mumps rise are shown in Figures 10 and 11. Both 
figures show 2-ME labile antibody to mumps virus, but better 
separation of the 2-ME labile--19S--antibody and 7S antibody 
is seen in Figure 11 which shows the results when the asymmetric 
gradient was used. A two-fold decrease in activity of DA 
antibody was seen in the bottom three fractions with the 
sample centrifuged in the asymmetric gradient (Figure ll), but 
not that in the symmetric gradient (Figure 12). 
Serum from monkey #2 obtained Ik days after first mumps 
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inoculation showed 19S and JS antibody to mumps, but only 7S 
to DA virus (Figure 12). Figures 13 and l4 show the results 
of centrifugation of serum from monkey #2 taken 8 days after 
DA inoculation. The results are similar to those for monkey #1 
taken 8 days after DA inoculation. Comparing Figure 13 to 
Figure 11, it can be seen that both show decrease in DA activity 
after 2-ME treatment of the lower three fractions, better seen 
with sera from monkey $2 than jfl. In both animals tested 
heterologous rise in mumps antibody after DA inoculation was 
accompanied by 19S mumps antibody production. 
Figures 15 and l6 show the results of centrifugation of 
serum from monkey #2 during a secondary response to mumps 
virus. The presence of 19S is shown by the four-fold decrease 
in titer seen in fraction 1 of the asymmetric gradient after 
treatment with 2-ME, The great amount of 7S present in this 
sera almost obliterates the 19S peak which can be demonstrated 
only in the bottom fraction of the asymmetric gradient. 
By use of sucrose gradients the presence of 19S antibody 
in the secondary response of monkeys to mumps and DA virus 
could be demonstrated, although amounts of 19S were too small 
for detection with 2-ME. Further 19S antibody against mumps 
was shown to be produced in response to DA inoculation. No 
19S DA antibody was seen in response to primary or secondary 
mumps inoculation. The asymmetric gradients were shown in 
the three instances used to be superior to the symmetric gradients* 
for separation of 19S and 7S activity of the serum samples used. 
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Antibody Absorption by Viral Antigens 
Results of absorption by mumps, DA, parainfluenza-3 and 
NDV antigens of sera obtained from the seven monkeys and 
chimpanzee #50 are shown in Tables 2 and 3* The sera used 
represent the following antibody responses: 1) early and late 
primary mumps inoculation, i.e. 11, l4 and 22 days following 
first mumps inoculation in monkeys #1-4, 2) heterologous mumps 
response to DA inoculation, i.e. 8 days following DA inoculation 
in monkeys #1 and 2, 3) secondary mumps inoculation, i.e. 11 days 
after second mumps inoculation in monkeys #2 and 3? 4) primary 
inoculation with DA, i.e. chimpanzee #50, 5) response to DA 
inoculation in monkeys with pre-existing DA antibodies, i.e. 
monkeys #1 and 2, sera from 8 days after DA inoculation, 6) 
heterologous DA rise in response to mumps, i.e. monkey #1, 
sera from 22 days after first mumps inoculation. 
In all instances specific antibody was completely removed 
or greatly reduced in titer by absorption with the homologous 
virus. Regardless of the virus used to stimulate antibody 
production manifest in a given serum sample, no significant 
decrease in titer of antibody against any virus other than 
that used for absorption was seen. 
To rule out the possibility that failure to demonstrate 
cross absorption was due to insufficient amount of antigen, a 
second absorption procedure was carried out. This was done 
after the sera was shown free of antibody against the virus 
used for absorption. No decrease in heterologous antibody 




Studies cited in Beview of Literature of antigenic 
cross reactivity between these viruses have been of two types: 
1) survey of populations for antibodies against these viruses, 
with or without concomitant attempts at virus isolation, and 
2) studies of the immunological response of laboratory animals 
Inoculated with one or more of these agents. Studies of the 
first type offer disadvantages that: 1) the infecting agent 
cannot always be known with certainty, 2) possibility of 
multiple infection cannot be eliminated, 3) previous experience 
with agents is difficult to evaluate, k) host factors cannot be 
evaluated or controlled, 5) mode of infection is not controlled, 
6) changes may occur in viral properties as virus undergoes 
uncontrolled passage in the environment. Studies with laboratory 
animals eliminate some of these disadvantages, but conclusions 
from these studies must be applied to consideration of human 
infections with caution. 
The high rate of natural infections of captive monkeys 
with parainfluenza-3 and -5 was confirmed in these studies. 
Of particular note in monkeys jfl-b was the high initial titers 
against parainfluenza-3. These titers decreased somewhat over 
the course of the study and may indicate the animals had 
acquired natural infection with this virus shortly before their 
use in these experiments, a similar circumstance to that found by 
12 
Churchill. The high level of parainfluenza-3 antibody makes 
heterologous response to this virus difficult to evaluate. 
Because all animals used had pre-existing titers to these 
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viruses, whether or not previous experience with one of these 
viruses is necessary to show a heterologous response could 
not be evaluated directly. It was shown that a heterologous 
response does not always occur even when pre-existing anti¬ 
bodies are present, but varies from individual to individual. 
Because of the widespread occurrence in laboratory animal 
populations of the viruses under study it is difficult to 
evaluate previous viral infections in the individual animals 
used. 
Cross reactivity in terms of ability to evoke heterologous 
antibody responses to members of the parainfluenza-mumps-KDV 
group has been shown to occur. One animal in seven showed a 
rise in DA. antibody with mumps infection; both animals inoculated 
with DA virus showed mumps rise. One of two animals inoculated 
with parainfluenza-3 responded with rise to DA. As cited 
earlier other workers have found extensive, inconsistant cross 
reactivity among these viruses. 
The findings that 19S antibody is present early in primary 
infection and that 7S persists long after disappearance of 
19S are in keeping with the work of others already cited. The 
presence of small amounts of 19S in secondary response to 
viral inoculation is in agreement with the findings of Svehag 
and Mandel that 19S antibody, in much smaller amounts than 7S, 
49 
is found in anamnestic response. ' 
The data presented also show- that 19S antibody was 
produced against mumps in response to DA virus inoculation. 
At the time DA virus was inoculated only 7S mumps antibody 
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was present. Other workers have postulated on the basis of 
their findings that presence of antigen is necessary for 19S 
production.50 According to this theory 19S antibody 
formation occurs only while there is persistance of antigen, 
rapidly falling off after loss of antigenic stimulus. The 
presence of 19S mumps antibody after DA inoculation vould 
indicate, according to this theory, that mumps antigen may 
be present. Many viral infections, including mumps, have 
been shown to persist for several months in a quiescent state. 
While this cannot be definitely ruled out, absence of 19S 
antibody just before DA inoculation makes it less likely. The 
other possibility in keeping with this theory is that DA virus 
provides the necessary antigenic stimulus for 19S mumps antibody 
production. This explanation implies the presence of a common 
structural antigenic component shared by these two viruses which 
is important in providing a stimulus for mumps HI antibody 
production. 
To evaluate this possibility that the heterologous antibody 
responses were due to common antigenic components shared by 
members of the parainfluenza-mumps-NDV group, absorption studies 
were carried out. The data presented show that HI antibody 
against mumps, DA or parainfluenza-3 will not react with either 
of the other two or NDV. Thus, the mumps antibody which was 
caused to increase in titer by DA virus could not be absorbed 
with DA virus. These studies indicate that common antigenic 
components could not be the explanation for the cross reactivity 
occurring between these viruses. 
The evidence presented would question whether or not 

31 
persistence of antigen is necessary in all cases for 
production of 19S antibody. The real significance of heter¬ 
ologous 19S antibody cannot be stated. A heterologous rise 
to DA following mumps inoculation in monkey #1 was not accompanied 
by detectible 19S production. 
Several workers have suggested the importance of host 
factors in determining whether or not a heterologous response 
will occur. The factor which has been suggested is previous 
experience with the virus, a heterologous response representing 
11 23 32 4o 
a special type of anamnestic antibody response.' ’ ’ ’ The 
data presented in this thesis are consistant with this theory, 
but do not offer proof that the pre-existing antibodies are a 
necessary factor. There must, however, also be viral factors 
operative in the production of a heterologous response, for 
a response against one of these agents is evoked by other 
members of this group. Thus, some factor--other than shared 
antigens--must be present during an infection with one of the 
parainfluenza-mumps-NDV viruses which causes the individual to 
react by producing heterologous antibody in certain cases. The 
delineation and relative importance of these viral and host 
factors awaits further investigation. 
Certain points can be inferred from the data presented. 
A rise in antibody against one of the agents studied may 
result from infection with another one of these agents; 
therefore, serologic diagnosis alone is inadequate. Demonstration 
of 19S antibody alone is not proof of a primary response, as 19S 
antibody may be found in a secondary response or a response 
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initiated by a virus other than that to which the specific 
19S antibody is found. The ability of a virus to cause 
production of heterologous antibody does not necessarily 
mean it shares antigens with the heterologous virus, or that 
the antibody produced will react with the virus causing its 
production. Failure of cross reactivity of antibodies to these 
viruses, along with the evidence that pre-existing experience 
with a virus is a factor determining heterologous response, 
make it seem unlikely that significant cross protection is 




Cross reactivity as shown by heterologous antibody 
response in monkeys was demonstrated between mumps, DA and 
parainfluenza-3 viruses. Presence of 19S antibodies was 
demonstrated to mumps after primary and secondary mumps 
inoculation and after DA inoculation which resulted in a 
mumps antibody rise. After mumps inoculation, 19S antibody 
to DA was not present although one animal showed DA 
antibody rise, but 19S antibody was present after DA 
inoculation. Absorption of sera with mumps, DA, parainfluenza 
and NDV antigens showed no cross absorption of any antibody 
present. Thus, it was shown that cross reactivity as expressed 
in ability to evoke a heterologous antibody response was not 
associated with common antigens which could be demonstrated 



















1 Mumps DA 3 
2 Mumps DA 3 Mumps 3 
3 Mumps Para-3 3 Mumps 3 
k Mumps Para-3 3 
5 Para-1 Mumps 5 
6 Polio-1 Mumps 5 
7 DA Para-1 2 Mumps 8 
Table 1. Sequence of virus inoculations in Rhesus monkeys 

Table 2. Results of antibody absorption of sera from 
monkeys fl-b. 
Table 3* Results of antibody absorption of sera from 
monkeys #5"7» 

I ST INOC 2 ND INOC 
□ HI ANTIBODY TITER 
□ HI ANTIBODY TITER AFTER TREATMENT WITH 2-ME 
Figure 1. Monkey #1. HI antibody titers following virus 
inoculations. 
DAYS AFTER INOCULATION 
□ HI ANTIBODY TITER 
£3 HI ANTIBODY TITER AFTER TREATMENT WITH 2-ME 
Figure 2. Monkey jf2. HI antibody titers following virus 
inoculations. 

□ HI ANTIBODY TITER 
E23 HI ANTIBODY TITER AFTER TREATMENT WITH 2-ME 
Figure 3. Monkey #3. HI antibody titers following virus 
inoculations. 
□ HI ANTIBODY TITER 
E3 HI ANTIBODY TITER AFTER TREATMENT WITH 2-ME 
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AFTER TREATMENT WITH 2-ME 
Figure 6. Monkey #6. 
inoculation. 
HI antibody titers following mumps 
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BOTTOM FRACTION NUMBER TOP 
Figure 8. Monkey #1 eight days after first mumps inoculation. 
Fractionation of serum in symmetric sucrose gradient. 
BOTTOM FRACTION NUMBER TOP 
Figure 9. Monkey #1 ninety days after first mumps inoculation. 
Fractionation of serum in symmetric sucrose gradient. 

BOTTOM FRACTION NUMBER TOP 
Figure 10. Monkey $1 eight days after DA inoculation. 
Fractionation of serum in symmetric sucrose gradient. 
Figure 11. Monkey #1 eight days after DA inoculation. 












BOTTOM FRACTION NUMBER TOP 
Figure 12. Monkey #2 fourteen days after first mumps inoculation. 
Fractionation of serum in symmetric sucrose gradient. 

BOTTOM FRACTION NUMBER 
Figure 13. Monkey #2 eight days after DA inoculation. 
Fractionation of serum in symmetric sucrose gradient. 
Figure Ik. Monkey #2 eight days after DA inoculation 













BOTTOM FRACTION NUMBER TOP 
Figure 1J. Monkey $2 eight days after second mumps inoculation. 
Fractionation of serum in symmetric sucrose gradient. 
Figure 16. Monkey #2 eight days after second mumps inoculation. 




1. Abinanti, F.R. and Heubner, R. J. 1959* The serologic 
relationships of strains of parainfluenza-3 virus 
from humans and cattle with respiratory disease. 
Virology 8:391* 
2. Abinanti, F. R., Hoerlin, A. B., Watson, R.L., and 
Heubner, R. J. 1961. Serologic studies of rnyxoviruses 
and parainfluenza-3 in cattle and the prevalance of 
antibodies in bovines. J. Immum. 86:505. 
3* Andrewes, C.H., Bang, F. B., and Burnet, F. M. 1956. 
A short description of the myxovirus group (influenza 
and related viruses). Virology 1:176. 
4. Andrewes, C. H., Bang, F. B., Chanock, R. M., and Zhdanov, 
V. M. 1959* Parainfluenza viruses 1, 2, and 3* 
Suggested names for recently described rnyxoviruses. 
Virology 8:129* 
5. Benedict, A.. A.., Larson, C,, and Nih-Khah, H. 1963* 
Synthesis of chicken antibodies of high and low 
molecular weight. Science 139:1302. 
6. Burnet, F. M., McCrea, and Stone, J. D. 1946. Modification 
of human red cells by virus action receptor gradient 
for virus action in human red cells. Brit. J. Exp. Path. 
27: 228. 
7. Chanock, R. M, 1958. Association of a new type of 
cytopathic myxovirus with infantile croup. J. Exptl. 
Med. 104: 555. 
8. Chanock, R. M., Parrott, R. H., Cook, M, K., Andrews, B. E., 
Bell, J.A., Reichederfer, T., and Kapikian, A. Z. 1958. 
Newly recognized rnyxoviruses from children with 
respiratory diseases. N.E.J.M. 258: 207* 
9* Chanock, R. M., Johnson, K. M., Cook, M. K., Wong, D. C., 
and Vargosko, A. 1961. The hemadsorption technique 
with special reference to the problem of naturally 
occurring simian parainfluenza viriises. Amer. Rev. 
Resp. Pis. 83: 125* 
10. Chanock, R. M., Vargosko, A., Luckey, A., Cook, M.K., 
Kapikian, A. Z., Reichederfer, T., and Parrott, R. H. 
1959* Association of hemadsorption viruses with 




Chanock, B. M., Wong, D. C., Huebner, E. J., and Bell, J. A. 
i960. Serologic responses of individuals infected 
with parainfluenza viruses. Am. J. Pub. Health. 
50: 1858. 
12. Churchill, A. E. 1963. The isolation of parainfluenza-3 
virus from fatal cases of pneumonia in erythrocebus 
patas monkeys. Brit. J. Exp. Path. 44: 529. 
13. Clarke, D. H. i960. Antigenic analysis of certain Group B 
arborviruses by antibody absorption. J. Exp. Med. 
Ill: 21. 
14. Cook, M. K., Andrews, B. E., Fox, H. H., Turner, H. C., 
James, W. D., and Chanock, E. M. 1959* Antigenic 
relations among the "newer" myxoviruses, parainfluenza. 
Am. J. 69; 250. 
15. Craghead, J. E., Cook, M. K., and Chanock, E. M. i960. 
Infection of hamsters with parainfluenza-3 virus. 
Proc. Soc. Exp. Bio. & Med. 104: 301. 
16. DeMeio, J. L. and Walker, D. L. 1957« Demonstration of 
antigenic relationship between mumps virus and 
hemagglutinating virus of Japan. J. Immunol. 78; 465* 
17. Deutsch, H. F. and Morton, J. I. 1957* Dissociation of 
human serum macroglobulins. Science 125: 600. 
18. Freymann, M. W., and Bang, F. B. 1948. Human conjunctivitis 
due to Newcastle Disease virus,in USA. Bull. Johns 
Hopkins Hosp. 84: 409. 
19. Frothingham, T. E. and Sanyakorn, C. K. 1961. Parainfluenza 
viruses in sourthern Louisiana. Pub. Health Bepts. 
76: 765. 
20. Hoerlein, A. B., Mansfield, M.E., Abinanti, F. E., and 
Huebner, E. J. 1959* Studies of shipping fever 
in cattle. I Parainfluenza-3 virus antibodies in 
feeder calves. J. Am. Vet. M. A, 135: 153* 
21. Horstmann, D. M. and Hsiung, G. D. 1963- Myxovirus 
infections and respiratory illness in children. Clin. 
Pediatrics. 2: 387. 
22. Hsiung, G. D. Diagnostic Virology 1964. The Yale University 
Press, New Haven. P. 56. 
23. Hsiung, G. D., Chang, P. W., Chadrado, E. B., and Isacson, 
P. 1965. J. Immunol. In press. 

48 
24. Hsiung, G. D., Isacson, P. and McCollum, R. 1962. Studies 
of a myxovirus isolated from human blood. I. Isolation 
and properties. J. Immunol. 88: 284. 
25. Hsiung, G. D., Isacson, P., and McCollum, R. W. 1962. 
Studies of a rnyxovirus isolated from human blood. III. 
Serologic reactions in persons with viral hepatitis. 
J. Immunol. 88: 300. 
26. Hsiung, G. D. Isacson, P., and Tucker, G. 1963. Studies 
of parainfluenza viruses. II. Serologic interrelation¬ 
ships in humans. Yale J. Bio. & Med. 35: 53^-* 
27. Ishida, N., Hinuma, Y., Numazak, Y., and Homrna, M. 1959« 
Common antigens shared by Dendai, mumps and NDV. 
Fed. Proc. 18: 575. 
28. Jensen, K. E., Davenport, F. M., Hennessey, A..V., and 
Francis, T. 1955* Persistent antibody orientation 
resulting from primary experiences with influenza 
virus. III. Characterization by serum absorption. 
Fed. Proc. l4: 466. 
29. Jensen, K. E. and Francis, T. 1961. The antigenic 
composition of influenza virus as measured by antibody 
absorption. J. Exp. Med. 98: 619. 
30. Jensen, K. E., Minuse, E. and Ackermann, W. W. 1955* 
Serologic evidences of American experience with 
newborn pneumonitis virus — type Sendai. J. Immunol. 
75: 71. 
31. Johnson, C. D. and Goodpasture, E. W. 193^* An 
investigation of the etiology of mumps. J. Exp. Med. 
59: 1. 
32. Johnson, K. M., Chanock, R. M., Cook, M. K., and Heubner, 
R. J. i960. Studies of a new human hemabsorption 
virus I. Isolation, properties and characterization. 
Am. J. Hyg. 71: 8l. 
33« Jordan, W. S. Jr., and Feller, A. E. 1950. The relation¬ 
ships of CF and hemagglutinating factors against the 
viruses of mumps and Newcastle Disease. Jour. Lab. 
and Clin. Med. 36: 369* 
34. Jungherr, E., Lugenbuhl, R. E., and Kilhan, L. 1949. 
Serologic relationships of mumps and NDV. Science 
110: 333. 
35* Keeny, A. H. and Hunter, M. C. 1950. Human infection 
with Newcastle virus of fowl. Arch. Ophth. 44: 573* 

^9 
36. Kilham, L., Jungherr, E. and Luginbuhl, E. E. 1949. 
Antihemagglutinating and neutralizing factors 
against NDV occurring in patients convalescent from 
mumps. J. Imraunol. 63: 37* 
37. King, N. B. and Gale, C. 1963• Studies on myxovirus 
parainfluenza-3 vacine for preventing shipping fever 
in cattle. Am. J, Vet. Med Assoc. l42: 88l. 
38. Kunkel, H. G. in Putnam, F. W. (ed.). The Plasma Proteins 
i960. Acad. Press, New York. p. 279* 
39* LaPlaca, M. and Mocovici, C. 1962. Distribution of para¬ 
influenza antibodies in different groups of populations 
in India, Italy, and Colorado. J. Immunol. 88: 72. 
40. Lennette, E. H., Jensen, F. W., Guenther, E. W., and Magoffin, 
E. L. 1963* Serologic responses to parainflueza 
viruses in patients with mumps virus infection. 
J. Lab. & Clin. Med. 6l: 780. 
41. LoSpalluto, J., Miller, W., Doward, B., and Fink, C. W. 
1962. The formation of macroglobulin antibodies. 
I. Studies on adult humans. J. Clin. Invest. 4l: 1415. 
42. Morgan, H. E., Enders, J. F., and Wagley, P. F. 1949. 
A hemolysin associated with the mumps virus. J. Exp. 
Med. 88: 503. 
43. Parrott, E. H., Vargoko, A., Luckey, M. S., Kim, H. W., 
Cumming, C. and Chanock, E. 1959. Clinical features 
of infection with hemadsorption viruses. N.E.J.M. 
260: 731. 
44. Schluederberg, A. E. S. Personal communication. 
45. Schultz, E. W. and Habel, K. 1964, SA virus -- a new 
member of the myxovirus group. J. Immunol. 82: 274. 
46. Shelokov, A., Vogel, J. E. and Chi, L. 1958. Hemadsorption 
test for viral agents in tissue culture with special 
reference to influenza. Proc. Soc. Exp. Bio. & Med. 
97: 802. 
4y. Speir,E.W.,Personal communication. 
48. Svehag, S. E., Mandel, B. 1964. The formation and properties 
of poliovirus neutralizing antibodies. I. 19S and JS 
antibody formation: Difference in kinetics and antigen 
dose requirement for induction. J. Exp. Med. 119: 1. 

50 
49. Svehag, S. E. and Mandel, B. 1964. The formation and 
properties of poliovirus-neutralizing antibodies 
II. 19S and 7'S antibody formation. Differences in 
antigen dose requirement for sustained synthesis, 
anamnesis and sensitivity to X-irradiation. J. Exp. 
Med. 119: 21. 
50. Uhr, J. W. and Finkelstein, M. S. 1963* Antibody 
formation of rapidly and slowly sedimenting antibodies 
and immunological memory to bacteriophage OX 174. 
J. Exp. Med. 117: 457. 
51. Uhr, J. W., Finkelstein, M. S. and Bauman, J. B. 1962. 
Antibody formation III. The primary and secondary 
response to bacteriophage OX 174 in guinea pigs. 
J. Exp. Med. 115: 655/ 
52. Von Euler, L., Kantor, F. S., and Hsiung, G. D. 1963. 
Studies of parainfluenza viruses. Clinical, path¬ 
ological, and virological observations. Yale J. 
Bio. & Med. 35: 523. 
53. Zhdanov, V. and Bukrinskaya, A. i960. Further con¬ 
sideration on nomenclature of parainfluenza viruses. 












YALE MEDICAL LIBRARY 
Manuscript Theses 
Unpublished theses submitted for the Master's and Doctor's degrees and 
deposited in the Yale Medical Library are to be used only with due regard to the 
rights of the authors. Bibliographical references may be noted, but passages 
must not be copied without permission of the authors, and without proper credit 
being given in subsequent written or published work. 
This thesis by has been 
used by the following persons, whose signatures attest their acceptance of the 
above restrictions. 
NAME AND ADDRESS DATE 

